HIV Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Mode, Test Type, End Use, and Region

Description

List of Tables

The global HIV diagnostics market size is expected to reach USD 5,396.32 million by 2034, according to a new study by Polaris Market Research. The report "HIV Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product (Consumables, Instruments, and Software and Services), Mode, Test Type, End Use, and Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The HIV diagnostics market encompasses a range of advanced technologies and testing methodologies designed to detect, monitor, and manage HIV infections across different stages. The market is experiencing robust expansion, driven by the increasing prevalence of HIV infections, rising awareness about early detection, and government-led initiatives promoting universal screening programs. Advancements in molecular diagnostics, rapid point-of-care (POC) testing, and AI-driven analytics are transforming HIV diagnostics market trends, enhancing the accuracy, efficiency, and accessibility of testing solutions. The growing emphasis on self-testing kits and decentralized diagnostic models is further contributing to market growth, particularly in low-resource settings where traditional laboratory infrastructure is limited.

The HIV diagnostics market demand is accelerating due to expanding government funding, strategic collaborations with nonprofit organizations, and rising investments in R&D for next-generation testing technologies. Increasing adoption of automated nucleic acid amplification tests (NAATs), antigen-antibody combination assays, and biosensor-based diagnostics is strengthening market value, ensuring early detection and effective disease management. The integration of digital health platforms, AI-powered diagnostic tools, and cloud-based data management is reshaping industry trends, enabling real-time disease surveillance and personalized treatment planning.

The HIV diagnostics market opportunity is expanding through public-private partnerships, regulatory support for innovative testing solutions, and the development of high-throughput screening platforms capable of handling large-scale testing requirements. The emergence of cost-effective, portable diagnostic devices is further contributing to market expansion, particularly in resource-constrained regions. The increasing focus on precision medicine, rapid result turnaround, and scalable diagnostic models is driving market dynamics, fostering technological advancements and competitive differentiation. The demand for high-sensitivity, multiplexed diagnostic platforms is expected to remain strong, ensuring long-term HIV diagnostics market growth through continuous innovations and strategic market penetration efforts.

HIV Diagnostics Market Report Highlights

In terms of product, the consumables segment dominated the HIV diagnostics market share in 2024 due to the high demand for reagents, test kits, and assay consumables across diagnostic laboratories.

Based on end use, the diagnostic laboratories segment accounted for the largest market share in 2024 due to the widespread adoption of advanced HIV diagnostic technologies and centralized testing models.

In 2024, North America accounted for the largest market share due to high testing rates and well-established healthcare infrastructure.

Asia Pacific is expected to register the highest CAGR during the forecast period due to increasing awareness initiatives, expansion of ART coverage, and technological advancements.

A few of the global key market players are Abbott; Apogee Flow Systems; BD; Beckman Coulter, Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; Janssen Global Services, LLC; Merck & Co. Inc.; Mylan N.V.; Point Care; QIAGEN; Siemens Healthcare GmbH; Sysmex Europe SE; VIIV Healthcare; and Zyomtronix, Inc.

Polaris Market Research has segmented the HIV diagnostics market report on the basis of product, mode, test type, end use, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Consumables
Instruments
Software and Services

By Mode Outlook (Revenue, USD Million, 2020-2034)

Self-Test
Lab-Based

By Test Type Outlook (Revenue, USD Million, 2020-2034)

Antibody Test
HIV-1 Screening Tests
HIV-1 Antibody Confirmatory Tests
HIV-2 & Group O Diagnostic Tests
Viral Load Test
CD4 Test
Others

By End Use Outlook (Revenue, USD Million, 2020-2034)

Diagnostic Laboratories
Hospitals & Clinics
Home Settings

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5496

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. HIV Diagnostics Market Insights

4.1. HIV Diagnostics Market - Market Snapshot
4.2. HIV Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Global HIV Prevalence
  - 4.2.1.2. Growing Government and NGO Initiatives
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. HIV Diagnostics Market Power Rating Trends
4.6. Value Chain Analysis

5. HIV Diagnostics Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
5.3. Consumables
- 5.3.1. HIV Diagnostics Market, by Consumables, by Region, 2020-2034 (USD Million)
5.4. Instruments
- 5.4.1. HIV Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Million)
5.5. Software and Services
- 5.5.1. HIV Diagnostics Market, by Software and Services, by Region, 2020-2034 (USD Million)

6. HIV Diagnostics Market, by Mode

6.1. Key Findings
6.2. Introduction
- 6.2.1. HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
6.3. Self-test
- 6.3.1. HIV Diagnostics Market, by Self-test, by Region, 2020-2034 (USD Million)
6.4. Lab-based
- 6.4.1. HIV Diagnostics Market, by Lab-based, by Region, 2020-2034 (USD Million)

7. HIV Diagnostics Market, by Test Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
7.3. Antibody Test
- 7.3.1. HIV Diagnostics Market, by Antibody Test, by Region, 2020-2034 (USD Million)
- 7.3.2. HIV-1 Screening Tests
  - 7.3.2.1. HIV Diagnostics Market, by HIV-1 Screening Tests, by Region, 2020-2034 (USD Million)
7.4. HIV-1 Antibody Confirmatory Tests
- 7.4.1. HIV Diagnostics Market, by HIV-1 Antibody Confirmatory Tests, by Region, 2020-2034 (USD Million)
7.5. HIV-2 & Group O Diagnostic Tests
- 7.5.1. HIV Diagnostics Market, by HIV-2 & Group O Diagnostic Tests, by Region, 2020-2034 (USD Million)
7.6. Viral load test
- 7.6.1. HIV Diagnostics Market, by Viral load test, by Region, 2020-2034 (USD Million)
7.7. CD4 test
- 7.7.1. HIV Diagnostics Market, by CD4 test, by Region, 2020-2034 (USD Million)
7.8. Others
- 7.8.1. HIV Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

8. HIV Diagnostics Market, by End Use

8.1. Key Findings
8.2. Introduction
- 8.2.1. HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
8.3. Diagnostic Laboratories
- 8.3.1. HIV Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
8.4. Hospitals & Clinics
- 8.4.1. HIV Diagnostics Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
8.5. Home Settings
- 8.5.1. HIV Diagnostics Market, by Home Settings, by Region, 2020-2034 (USD Million)

9. HIV Diagnostics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. HIV Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
9.3. HIV Diagnostics Market - North America
- 9.3.1. North America: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
- 9.3.2. North America: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
- 9.3.3. North America: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 9.3.4. North America: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.3.5. HIV Diagnostics Market - US
  - 9.3.5.1. US: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.3.5.2. US: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.3.5.3. US: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.3.5.4. US: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.3.6. HIV Diagnostics Market - Canada
  - 9.3.6.1. Canada: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
9.4. HIV Diagnostics Market - Europe
- 9.4.1. Europe: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
- 9.4.2. Europe: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
- 9.4.3. Europe: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 9.4.4. Europe: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.5. HIV Diagnostics Market - UK
  - 9.4.5.1. UK: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.5.2. UK: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.5.3. UK: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.5.4. UK: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.6. HIV Diagnostics Market - France
  - 9.4.6.1. France: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.6.2. France: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.6.3. France: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.6.4. France: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.7. HIV Diagnostics Market - Germany
  - 9.4.7.1. Germany: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.8. HIV Diagnostics Market - Italy
  - 9.4.8.1. Italy: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.9. HIV Diagnostics Market - Spain
  - 9.4.9.1. Spain: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.10. HIV Diagnostics Market - Netherlands
  - 9.4.10.1. Netherlands: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.11. HIV Diagnostics Market - Russia
  - 9.4.11.1. Russia: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.4.12. HIV Diagnostics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
9.5. HIV Diagnostics Market - Asia Pacific
- 9.5.1. Asia Pacific: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.5. HIV Diagnostics Market - China
  - 9.5.5.1. China: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.5.2. China: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.5.3. China: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.5.4. China: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.6. HIV Diagnostics Market - India
  - 9.5.6.1. India: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.6.2. India: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.6.3. India: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.6.4. India: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.7. HIV Diagnostics Market - Malaysia
  - 9.5.7.1. Malaysia: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.8. HIV Diagnostics Market - Japan
  - 9.5.8.1. Japan: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.9. HIV Diagnostics Market - Indonesia
  - 9.5.9.1. Indonesia: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.10. HIV Diagnostics Market - South Korea
  - 9.5.10.1. South Korea: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.11. HIV Diagnostics Market - Australia
  - 9.5.11.1. Australia: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.5.12. HIV Diagnostics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
9.6. HIV Diagnostics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.6.5. HIV Diagnostics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.6.6. HIV Diagnostics Market - UAE
  - 9.6.6.1. UAE: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.6.7. HIV Diagnostics Market - Israel
  - 9.6.7.1. Israel: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.6.8. HIV Diagnostics Market - South Africa
  - 9.6.8.1. South Africa: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.6.9. HIV Diagnostics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
9.7. HIV Diagnostics Market - Latin America
- 9.7.1. Latin America: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
- 9.7.2. Latin America: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
- 9.7.3. Latin America: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
- 9.7.4. Latin America: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.7.5. HIV Diagnostics Market - Mexico
  - 9.7.5.1. Mexico: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.7.6. HIV Diagnostics Market - Brazil
  - 9.7.6.1. Brazil: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.7.7. HIV Diagnostics Market - Argentina
  - 9.7.7.1. Argentina: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)
- 9.7.8. HIV Diagnostics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: HIV Diagnostics Market, by Product, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: HIV Diagnostics Market, by Mode, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: HIV Diagnostics Market, by End Use, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: HIV Diagnostics Market, by Test Type, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Apogee Flow Systems
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. BD
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Beckman Coulter, Inc.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Bristol-Myers Squibb Company
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. F. Hoffmann-La Roche Ltd.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Gilead Sciences, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Janssen Global Services, LLC
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Merck & Co. Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Mylan N.V.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Point Care
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. QIAGEN.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Siemens Healthcare GmbH
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Sysmex Europe SE
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. VIIV Healthcare
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
11.16. Zyomtronix, Inc.
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development